State Mode
Develops fungi-derived compounds intended to support brain regulation, focus and calm
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-10
About State Mode
State Mode develops natural, fungi-derived compounds intended to help regulate brain function and support focus, calm and resilience. It is testing and refining its formulations through a trials programme.
The company is registered in Ascot, United Kingdom, and was founded in 2022.
Product: Natural, fungi-derived compounds intended to support brain regulation, focus, calm and resilience.
Jobs at State Mode
More biotech & pharma companies
Sterling Pharma Solutions
Contract development and manufacturing of small-molecule APIs and ADCs for pharma and biotech companiesStimoxygen
Develops oxygen-generating nanoparticles for cancer treatment research and therapeutic applicationsNew on EvolcStirling Anglian Pharmaceuticals
Develops and supplies specialty branded medicines for UK healthcare providers and NHS stakeholdersStorm Therapeutics
Clinical-stage biotech developing small-molecule RNA modifying enzyme inhibitors for cancer and other diseasesStrameno
Develops marine microorganism strains producing DHA and carotenoids for food, feed and nutraceutical applicationsNew on EvolcStratosvir
Develops engineered viral immunotherapies for solid tumours and their metastases, aiming at cancer patientsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.